Pathogenesis and clinical presentation of acute heart failure;Patogenia y presentación clínica de la insuficiencia cardiaca aguda

Revista Espanola de Cardiologia

Volumn 68, Issue 4, 2015, Pages 331-337

  Ponikowski, Piotr ^a,b   Jankowska, Ewa A ^a,b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b MILITARY HOSPITAL   (Poland)

Author keywords

Acute heart failure; Clinical profiles; Management; Pathophysiology

Indexed keywords

ACUTE HEART FAILURE; ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; ACUTE DISEASE; DECISION MAKING; DISEASE COURSE; DISEASE MANAGEMENT; HEART FAILURE;

ACUTE DISEASE; DECISION MAKING; DISEASE MANAGEMENT; DISEASE PROGRESSION; HEART FAILURE; HUMANS;

EID: 84925458556     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2015.01.003     Document Type: Article

References (48)

1. J.J. McMurray, S. Adamopoulos, S.D. Anker, A. Auricchio, M. Böhm, and K. Dickstein ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
2. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, and P.A. Poole-Wilson ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 2008 933 989
3. P.B. Adamson Pathophysiology of the transition from chronic compensated and acute decompensated heart failure: new insights from continuous monitoring devices Curr Heart Fail Rep 6 2009 287 292
4. M. Gheorghiade, and P.S. Pang Acute heart failure syndromes J Am Coll Cardiol 53 2009 557 573
5. C.N. Marti, V.V. Georgiopoulou, and A.P. Kalogeropoulos Acute heart failure: patient characteristics and pathophysiology Curr Heart Fail Rep 10 2013 427 433
6. O. Milo, G. Cotter, E. Kaluski, A. Brill, A. Blatt, and R. Krakover Comparison of inflammatory and neurohormonal activation in cardiogenic pulmonary edema secondary to ischemic versus nonischemic causes Am J Cardiol 92 2003 222 226
7. A. Rydlewska, E.A. Jankowska, B. Ponikowska, L. Borodulin-Nadzieja, W. Banasiak, and P. Ponikowski Changes in autonomic balance in patients with decompensated chronic heart failure Clin Auton Res 21 2011 47 54
8. A. Maisel, Y. Xue, K. Shah, C. Mueller, R. Nowak, and W.F. Peacock Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study Circ Heart Fail 4 2011 613 620
9. K. Stangl, T. Dschietzig, C. Richter, M. Laule, V. Stangl, and E. Tanis Pulmonary release and coronary and peripheral consumption of big endothelin and endothelin-1 in severe heart failure: acute effects of vasodilator therapy Circulation 102 2000 1132 1138
10. A. Maisel, C. Mueller, R.M. Nowak, W.F. Peacock, P. Ponikowski, and M. Mockel Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial J Am Coll Cardiol 58 2011 1057 1067
11. P.L. Santaguida, A.C. Don-Wauchope, M. Oremus, R. McKelvie, U. Ali, and S.A. Hill BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review Heart Fail Rev 19 2014 453 470
12. S.U. Rehman, T. Mueller, and J.L. Januzzi Jr. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure J Am Coll Cardiol 52 2008 1458 1465
13. S. Di Somma, V. Pittoni, S. Raffa, L. Magrini, G. Gagliano, and R. Marino IL-18 stimulates B-type natriuretic peptide synthesis by cardiomyocytes in vitro and its plasma levels correlate with B-type natriuretic peptide in non-overloaded acute heart failure patients Eur Heart J Acute Cardiovasc Care 2013 Jul 29 [Epub ahead of print]
14. S.L. Chow, S.A. O'Barr, J. Peng, E. Chew, F. Pak, and R. Quist Modulation of novel cardiorenal and inflammatory biomarkers by intravenous nitroglycerin and nesiritide in acute decompensated heart failure: an exploratory study Circ Heart Fail 4 2011 450 455
15. Z. Ungvári, S.A. Gupte, F.A. Recchia, S. Bátkai, and P. Pacher Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure Curr Vasc Pharmacol 3 2005 221 229
16. S.J. Nicholls, and S.L. Hazen Myeloperoxidase and cardiovascular disease Arterioscler Thromb Vasc Biol 25 2005 1102 1111
17. D.A. Pascual-Figal, J.A. Hurtado-Martinez, B. Redondo, M.J. Antolinos, J.A. Ruiperez, and M. Valdes Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients Eur J Heart Fail 9 2007 518 524
18. K. Ramasubbu, A. Deswal, W. Chan, D. Aguilar, and B. Bozkurt Echocardiographic changes during treatment of acute decompensated heart failure: insights from the ESCAPE trial J Card Fail 18 2012 792 798
19. T.B. Horwich, J. Patel, W.R. MacLellan, and G.C. Fonarow Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure Circulation 108 2003 833 838
20. W.F. Peacock, 4th, T. De Marco, G.C. Fonarow, D. Diercks, J. Wynne, F.S. Apple ADHERE Investigators Cardiac troponin and outcome in acute heart failure N Engl J Med 358 2008 2117 2126
21. A. Shirakabe, K. Asai, N. Hata, S. Yokoyama, T. Shinada, and N. Kobayashi Clinical significance of matrix metalloproteinase (MMP)-2 in patients with acute heart failure Int Heart J 51 2010 404 410
22. M.D. Filipe, W.C. Meijers, A. Rogier van der Velde, and R.A. De Boer Galectin-3 and heart failure: Prognosis, prediction and clinical utility Clin Chim Acta 2014 10.1016/j.cca.2014.10.009
23. J. Bauersachs, and J.D. Widder Endothelial dysfunction in heart failure Pharmacol Rep 60 2008 119 126
24. G. Poelzl, and J. Auer Cardiohepatic syndrome Curr Heart Fail Rep 2014 Nov 13 [Epub ahead of print]
25. A. Kazory, and U. Elkayam Cardiorenal interactions in acute decompensated heart failure: contemporary concepts facing emerging controversies J Card Fail 20 2014 1004 1011
26. M.M. Givertz, D. Postmus, H.L. Hillege, G.A. Mansoor, B.M. Massie, and B.A. Davison Renal function trajectories and clinical outcomes in acute heart failure Circ Heart Fail 7 2014 59 67
27. A. Bouquegneau, J.M. Krzesinski, P. Delanaye, and E. Cavalier Biomarkers and physiopathology in the cardiorenal syndrome Clin Chim Acta 2014 10.1016/j.cca.2014.10.041
28. G. Virzì, S. Day, M. de Cal, G. Vescovo, and C. Ronco Heart-kidney crosstalk and role of humoral signaling in critical illness Crit Care 18 2014 201
29. S.I. Chaudhry, Y. Wang, J. Concato, T.M. Gill, and H.M. Krumholz Patterns of weight change preceding hospitalization for heart failure Circulation 116 2007 1549 1554
30. A.E. Burchell, P.A. Sobotka, E.C. Hart, A.K. Nightingale, and M.E. Dunlap Chemohypersensitivity and autonomic modulation of venous capacitance in the pathophysiology of acute decompensated heart failure Curr Heart Fail Rep 10 2013 139 146
31. C. Fallick, P.A. Sobotka, and M.E. Dunlap Sympathetically mediated changes in capacitance: redistribution of the venous reservoir as a cause of decompensation Circ Heart Fail 4 2011 669 675
32. G. Cotter, M. Metra, O. Milo-Cotter, H.C. Dittrich, and M. Gheorghiade Fluid overload in acute heart failure - re-distribution and other mechanisms beyond fluid accumulation Eur J Heart Fail 10 2008 165 169
33. S.S. Thomas, and A. Nohria Hemodynamic classifications of acute heart failure and their clinical application: an update Circ J 76 2012 278 286
34. P.G. Steg, O.H. Dabbous, L.J. Feldman, A. Cohen-Solal, M.C. Aumont, J. López-Sendón Global Registry of Acute Coronary Events Investigators Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE) Circulation 109 2004 494 499
35. G. Greenberg, E. Cohen, M. Garty, Z. Iakobishvili, A. Sandach, and S. Behar Outcomes of acute heart failure associated with acute coronary syndrome versus other causes Acute Card Care 13 2011 87 92
36. A. Nohria, S.W. Tsang, J.C. Fang, E.F. Lewis, J.A. Jarcho, and G.H. Mudge Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure J Am Coll Cardiol 41 2003 1797 1804
37. L.W. Stevenson Design of therapy for advanced heart failure Eur J Heart Fail 7 2005 323 331
38. M. Metra, G.M. Felker, V. Zacà, S. Bugatti, C. Lombardi, and L. Bettari Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy Int J Cardiol 144 2010 175 179
39. G. Cotter, M. Metra, B.D. Weatherley, H.C. Dittrich, B.M. Massie, and P. Ponikowski Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure - association with signs and symptoms, hospitalization duration, and 60-day outcomes Cardiology 115 2010 29 36
40. M. Metra, J.R. Teerlink, G.M. Felker, B.H. Greenberg, G. Filippatos, and P. Ponikowski Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study Eur J Heart Fail 12 2010 1130 1139
41. F. Zannad, A.A. Garcia, S.D. Anker, P.W. Armstrong, G. Calvo, and J.G. Cleland Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document Eur J Heart Fail 15 2013 1082 1094
42. J.R. Teerlink, G. Cotter, B.A. Davison, G.M. Felker, G. Filippatos, B.H. Greenberg RELAXin in Acute Heart Failure (RELAX-AHF) Investigators Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial Lancet 381 2013 29 39
43. B.M. Massie, C.M. O'Connor, M. Metra, P. Ponikowski, J.R. Teerlink, G. Cotter PROTECT Investigators and Committees Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure N Engl J Med 363 2010 1419 1428
44. A.P. Maggioni, S.D. Anker, U. Dahlström, G. Filippatos, P. Ponikowski, F. Zannad Heart Failure Association of the ESC Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry Eur J Heart Fail 15 2013 1173 1184
45. E.A. Jankowska, M. Kasztura, M. Sokolski, M. Bronisz, S. Nawrocka, and W. Oleskowska-Florek Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure Eur Heart J 35 2014 2468 2476
46. A.S. Desai, and L.W. Stevenson Rehospitalization for heart failure: predict or prevent? Circulation 126 2012 501 506
47. R.J. Mentz, G.M. Felker, T. Ahmad, W.F. Peacock, B. Pitt, and M. Fiuzat Learning from recent trials and shaping the future of acute heart failure trials Am Heart J 166 2013 629 635
48. G.M. Felker, P.S. Pang, K.F. Adams, J.G. Cleland, G. Cotter, K. Dickstein International AHFS Working Group Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward Circ Heart Fail 3 2010 314 325